One of the SKIF residents of will be the State Research Center for Virology and Biotechnology Vector, which currently works at development of a vaccine against the coronavirus. “Vector researchers should be able to conduct biological studies already in 2024 - at 2 of the 6 experimental facilities of the 1st stage. In 2025, it is planned to open a specialized installation, located in a separate building and equipped for Vector’s full-fledged research.
The building with all biological safety and security systems will be designed, among other facilities, by the Central Design and Technological Institute,” commented Valery Bukhtiyarov, director of the Federal Research Center “Boreskov Institute of Catalysis” (a part of Siberian Branch of the Russian Academy of Sciences), which will act as the developer for the SKIF infrastructure.
“SKIF is an absolutely unique project, strongly awaited by the scientific world, and we are proud to be a part of it. The facility will be designed using the most advanced technologies, such as digital information modeling,” said Mikhail Tarasov, Director General of the Central Design and Technological Institute
